|
|
||||||||
ORIGINAL RESEARCH |
From the Departments of Obstetrics and Gynecology and Molecular Human Genetics, Baylor College of Medicine, Houston, Texas.
Address reprint requests to: Anthony R. Gregg, MD Department of Obstetrics and Gynecology Baylor College of Medicine 6550 Fannin, Suite 901 Houston, TX 77030 E-mail: agregg{at}bcm.tmc.edu
Objective: To identify associations between polymorphisms within the interleukin-1ß gene cluster, all of which increase protein expression, and preeclampsia.
Methods: We genotyped a Hispanic population (69 women with preeclampsia and 47 controls) for two polymorphisms of the interleukin-1ß gene (promoter region and exon 5) and one polymorphism of the interleukin-1 receptor antagonist gene in intron 2. Clinical data were collected from medical records. Values are given as means or medians. Statistical power to identify a difference in occurrence of interleukin-1ß promoter, interleukin-1ß exon 5, and interleukin-1 receptor antagonist gene polymorphisms in women with preeclampsia compared with controls was 21%, 15.9%, and 30.9%, respectively.
Results: We found no association between any single polymorphism and occurrence of preeclampsia. Among women with preeclampsia, those with polymorphism of interleukin-1 receptor antagonist gene had higher mean systolic blood pressure (BP) at admission (178 ± 33.4 versus 159 ± 19.5 mmHg, P = .039). When all three polymorphisms combined were evaluated, women with preeclampsia and at least three mutant alleles (n = 8) had higher mean systolic BP at admission (182 ± 30 versus 160 ± 20.5 mmHg, P = .009) and increased alanine aminotransferase (67 [101024] versus 20 [3407] IU/L, P = .04) and aspartate aminotransferase (119 [252239] versus 24 [4489] IU/L, P = .002). At admission, BP in controls was independent of any polymorphism identified.
Conclusion: Although the power of this study was limited, our data do not support a role for polymorphisms of the interleukin-1ß and interleukin-1 receptor antagonist genes in the pathogenesis of preeclampsia among Hispanic women. Our findings do suggest that polymorphisms within the gene cluster might influence severity of preeclampsia.
This article has been cited by other articles:
![]() |
C. J. Lockwood, C. Oner, Y. H. Uz, U. A. Kayisli, S. J. Huang, L. F. Buchwalder, W. Murk, E. F. Funai, and F. Schatz Matrix Metalloproteinase 9 (MMP9) Expression in Preeclamptic Decidua and MMP9 Induction by Tumor Necrosis Factor Alpha and Interleukin 1 Beta in Human First Trimester Decidual Cells Biol Reprod, June 1, 2008; 78(6): 1064 - 1072. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Lockwood, C.-F. Yen, M. Basar, U. A. Kayisli, M. Martel, I. Buhimschi, C. Buhimschi, S. J. Huang, G. Krikun, and F. Schatz Preeclampsia-Related Inflammatory Cytokines Regulate Interleukin-6 Expression in Human Decidual Cells Am. J. Pathol., June 1, 2008; 172(6): 1571 - 1579. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. S. How, T. Aung, X. Chew, V. H. K. Yong, M. C. C. Lim, K. Y. C. Lee, J.-Y. Toh, Y. Li, J. Liu, and E. N. Vithana Lack of Association between Interleukin-1 Gene Cluster Polymorphisms and Glaucoma in Chinese Subjects Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2123 - 2126. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Lockwood, P. Toti, F. Arcuri, E. Norwitz, E. F. Funai, S.-T. J. Huang, L. F. Buchwalder, G. Krikun, and F. Schatz Thrombin Regulates Soluble fms-Like Tyrosine Kinase-1 (sFlt-1) Expression in First Trimester Decidua: Implications for Preeclampsia Am. J. Pathol., April 1, 2007; 170(4): 1398 - 1405. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Lockwood, P. Matta, G. Krikun, L. A. Koopman, R. Masch, P. Toti, F. Arcuri, S.-T. J. Huang, E. F. Funai, and F. Schatz Regulation of Monocyte Chemoattractant Protein-1 Expression by Tumor Necrosis Factor-{alpha} and Interleukin-1{beta} in First Trimester Human Decidual Cells: Implications for Preeclampsia Am. J. Pathol., February 1, 2006; 168(2): 445 - 452. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |